Meitav Dash Investments »

Halozyme Therapeutics shares owned by Meitav Dash Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Meitav Dash Investments from 13F filings

Historical chart of Meitav Dash Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Meitav Dash Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Meitav Dash Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.1M 33k 63.81
2024-12-31 $1.9M 39k 47.81
2024-09-30 $4.0M 63k 63.74

More positions owned by Meitav Dash Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Select Sector Spdr Tr Financial (XLF)
Advanced Micro Devices (AMD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Communication (XLC)
NVIDIA Corporation (NVDA)
Elbit Sys Ord (ESLT)
NOVA MEASURING Instruments L (NVMI)
Vaneck Etf Trust Semiconductr Etf (SMH)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Icl Group SHS (ICL)
Tower Semiconductor Shs New (TSEM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Meitav Dash Investments

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics